R&D FOR BEHAVIOR CHANGE Collaborative development to automate and assess digital health interventions.


Learn about our views on agile science, evidence-building, patient adherence and behavior change technologies.


Johns Hopkins Study Demonstrates 16% Increase in Patient Adherence Using MEMOTEXT

  • October 2014

Amos Adler at Mobile Health 2011 presenting: What Really Works (CNW Group/MEMOTEXT Personalized Adherence Solutions)

TORONTO, June 8, 2011 /CNW/ – MEMOTEXT presented “The Impact of Automated Dosing Reminders on Medication Adherence Using HealthVault,” conducted by Johns Hopkins University and funded by the Microsoft HealthVault Be Well Fund at Mobile Health 2011: What Really Works conference at Stanford University May 4-5, 2011.

Preliminary results from the Automated Dosing Reminder Study (ADRS) were also presented at the March 2011 annual meeting of American Glaucoma Society.

Of the 428 participants analyzed thus far, the study showed an increase in adherence from 51 to 67% with daily glaucoma therapy using a MEMOTEXT adherence solution integrated with Microsoft HealthVault. A control group with no intervention showed no change in adherence. The study to be published this year demonstrates efficacy of MEMOTEXT solutions integrated with a personal health record.

“We are extremely pleased with the results of this adherence study.” says Amos Adler, president of MEMOTEXT. “Working with Dr. Boland and his team helped make this a success and we are proud of the impact this will have on the future of adherence and people living with glaucoma.”

Back to Top